NCT02618967View on ClinicalTrials.gov

Single Ascending Dose Study of AMG 570 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

March 28, 2016

Primary Completion Date

September 6, 2018

Study Completion Date

December 3, 2018

Conditions
Systemic Lupus Erythematosus
Interventions
BIOLOGICAL

AMG 570

7 dose levels of AMG 570 administered as single dose subcutaneous in healthy volunteers.

BIOLOGICAL

AMG 570 Matching Placebo

Placebo administered as single dose subcutaneous in healthy volunteers.

Trial Locations (3)

47710

Research Site, Evansville

53704

Research Site, Madison

66212

Research Site, Overland Park

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY